Cartia XT Diltiazem Hydrochloride Capsules Recalled for Incorrect Expiration Date
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg due to an incorrect expiration date printed on the label. The affected lot was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II labeling error involving incorrect expiration date information. The source text does not report any hospitalizations, illnesses, or injuries, and this is a labeling/documentation issue rather than a manufacturing defect, making it a moderate-severity precautionary recall.
Plain-English summary
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, 90-capsule bottles, due to an incorrect expiration date on the product label. The affected lot is Lot # 100023805, labeled with an expiration date of 05/2023.
The recalled product was distributed nationwide in the United States. A total of 32,316 bottles are affected by this recall.
Patients currently taking this medication from the affected lot should contact their healthcare provider or pharmacist for guidance. Consumers should not use the affected product and should return it to the pharmacy where it was dispensed or contact the manufacturer for instructions on how to proceed.
The recalled product
- Product
- CARTIA (DILTIAZEM HYDROCHLORIDE)
- Brand
- CARTIA
- Manufacturer
- Teva Pharmaceuticals USA
- Affected units
- 32,316
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 100023805
- Exp. Date 05/2023
UPCs (4)
- 0362037598906
- 0362037599903
- 0362037597909
- 0362037600906
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · mis labeling
See all →- CriticalFDA Recalls Gluten-Free Veggie Chips for Undeclared Wheat
FDA (Food) · 2026-09-16
- ModerateWheel Pros Recalls 549 Avix TrailTek RT Tires for Incorrect Markings
NHTSA · 2026-09-10
- LowB Braun Recalls Discofix Stopcock Sets Due to Incorrect Expiration Date
FDA (Devices) · 2026-09-09
- HighPrince Italian Bread Recalled for Undeclared Sesame Allergen
FDA (Food) · 2026-09-09
- ModerateWonton Skin Recalled for Undeclared Red Dye
FDA (Food) · 2026-09-09